Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- PMID: 32616623
- PMCID: PMC7371481
- DOI: 10.1136/medethics-2020-106476
Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
Abstract
A number of papers have appeared recently arguing for the conclusion that it is ethically acceptable to infect healthy volunteers with severe acute respiratory syndrome coronavirus 2 as part of research projects aimed at developing COVID-19 vaccines or treatments. This position has also been endorsed in a statement by a working group for the WHO. The papers generally argue that controlled human infection (CHI) is ethically acceptable if (1) the risks to participants are low and therefore acceptable, (2) the scientific quality of the research is high, (3) the research has high social value, (4) participants give full informed consent, and (5) there is fair selection of participants. All five conditions are necessary premises in the overall argument that such research is ethically acceptable. The arguments concerning risk and informed consent have already been critically discussed in the literature. This paper therefore looks specifically at the arguments relating to condition 3 'high social value' and condition 5 'fair selection of participants' and shows that whereas they may be valid, they are not sound. It is highly unlikely that the conditions that are necessary for ethical CHI trials to take place will be fulfilled. Most, if not all, CHI trials will thus be well intentioned but unethical.
Keywords: research ethics; research on special populations.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Ethics of controlled human infection to address COVID-19.Science. 2020 May 22;368(6493):832-834. doi: 10.1126/science.abc1076. Epub 2020 May 7. Science. 2020. PMID: 32381590 No abstract available.
References
-
- Devlin H. WHO conditionally backs Covid-19 vaccine trials that infect people. The guardian, 08.05.2020. Available: https://www.theguardian.com/science/2020/may/08/who-conditionally-backs-... [Accessed 15 Jun 2020].
-
- Chappell RY, Singer P. Pandemic ethics: the case for risky research. research ethics, 2020. Available: https://doi.org/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous